IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs based on its unique ability to create new muscle with full length dystrophin in Becker Muscular Dystrophy(BMD). IPS ...
Vioneo (Antwerp, Belgium) and Honeywell International, Inc. (Charlotte, N.C.) announced that Honeywell’s technology will be used by Vioneo as part of its ...
Vioneo will use Honeywell's advanced methanol-to-olefins conversion technology to produce plastics without the need for traditional feedstock made from fossil fuels ...